STOCK TITAN

[Form 3] Medtronic plc Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Medtronic director filing reports no beneficial ownership. The Form 3 shows William R. Jellison as a director of Medtronic plc (MDT) and indicates he does not beneficially own any ordinary shares or derivative securities. The filing was submitted as an initial statement and was signed by an attorney-in-fact. No transactions, holdings, or indirect ownership interests are reported.

Il direttore di Medtronic presenta una segnalazione di nessuna proprietà effettiva. Il modulo 3 mostra William R. Jellison come direttore di Medtronic plc (MDT) e indica che non possiede in modo beneficiante azioni ordinarie né strumenti derivati. La pratica è stata presentata come dichiarazione iniziale ed è stata firmata da un procuratore-in-fatto. Non vengono riportate transazioni, partecipazioni o interessi di proprietà indiretta.

El director de Medtronic presenta un informe de ausencia de titularidad beneficiosa. El Formulario 3 muestra a William R. Jellison como director de Medtronic plc (MDT) y señala que no posee de forma beneficiosa ninguna acción ordinaria ni valores derivados. El informe se presentó como declaración inicial y fue firmado por un apoderado. No se informa de transacciones, participaciones ni intereses de propiedad indirecta.

메드트로닉 이사, 수익적 소유 없음 보고 Form 3은 William R. Jellison을 Medtronic plc (MDT)의 이사로 제시하고 그가 보통주나 파생증권을 실질적으로 소유하지 않음을 나타냅니다. 이 서류는 최초 진술로 제출되었으며 대리인에 의해 서명되었습니다. 거래 내역, 보유 현황 또는 간접 소유권은 보고되지 않았습니다.

Le directeur de Medtronic dépose un avis indiquant qu’il n’a aucun droit de propriété bénéficiaire. Le formulaire 3 présente William R. Jellison en tant que directeur de Medtronic plc (MDT) et indique qu’il ne détient pas, de manière bénéficiaire, d’actions ordinaires ni de titres dérivés. Le dépôt a été soumis comme déclaration initiale et signé par un mandataire. Aucune transaction, participation ou intérêt de propriété indirecte n’est reporté.

Medtronic-Direktor meldet keine begünstigten Eigentumsverhältnisse. Das Formular 3 führt William R. Jellison als Direktor von Medtronic plc (MDT) auf und gibt an, dass er keine Beneficial Ownership an normalen Aktien oder derivativen Wertpapieren besitzt. Die Einreichung erfolgte als anfängliche Erklärung und wurde von einem Bevollmächtigten unterschrieben. Es werden keine Transaktionen, Beteiligungen oder indirekten Eigentumsinteressen gemeldet.

مدير Medtronic يقدم تقريراً يفيد بأنه لا يملك ملكية مستفيدة. يُظهر النموذج 3 ويليام ر. جيليسون كمدير في Medtronic plc (MDT) ويدل على أنه لا يمتلك بشكل مستفيد أي أسهم عادية أو أوراق مالية مشتقة. تم تقديم الملف كتصريح ابتدائي وتوقعه وكيل بذاته. لا تُذكر معاملات أو حيازات أو مصالح ملكية غير مباشرة في التقرير.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director listed but reports zero ownership; routine disclosure with limited investor impact.

The filing documents that William R. Jellison is identified as a director of Medtronic plc and has filed an initial Form 3 reporting no direct or indirect beneficial ownership of ordinary shares or derivative securities. This is a straightforward SEC Section 16 disclosure signaling that the individual currently holds no equity stake to disclose; it does not indicate any stock-based compensation, option grants, or transfers.

TL;DR: Administrative initial filing only; no material holdings or transactions disclosed.

The Form 3 is an initial ownership statement reflecting a reporting obligation rather than a market-moving event. Because the report shows zero shares and no derivatives, there is no immediate effect on share count, insider ownership metrics, or potential dilution. The document provides limited information for valuation or governance analysis beyond confirming the reporting relationship.

Il direttore di Medtronic presenta una segnalazione di nessuna proprietà effettiva. Il modulo 3 mostra William R. Jellison come direttore di Medtronic plc (MDT) e indica che non possiede in modo beneficiante azioni ordinarie né strumenti derivati. La pratica è stata presentata come dichiarazione iniziale ed è stata firmata da un procuratore-in-fatto. Non vengono riportate transazioni, partecipazioni o interessi di proprietà indiretta.

El director de Medtronic presenta un informe de ausencia de titularidad beneficiosa. El Formulario 3 muestra a William R. Jellison como director de Medtronic plc (MDT) y señala que no posee de forma beneficiosa ninguna acción ordinaria ni valores derivados. El informe se presentó como declaración inicial y fue firmado por un apoderado. No se informa de transacciones, participaciones ni intereses de propiedad indirecta.

메드트로닉 이사, 수익적 소유 없음 보고 Form 3은 William R. Jellison을 Medtronic plc (MDT)의 이사로 제시하고 그가 보통주나 파생증권을 실질적으로 소유하지 않음을 나타냅니다. 이 서류는 최초 진술로 제출되었으며 대리인에 의해 서명되었습니다. 거래 내역, 보유 현황 또는 간접 소유권은 보고되지 않았습니다.

Le directeur de Medtronic dépose un avis indiquant qu’il n’a aucun droit de propriété bénéficiaire. Le formulaire 3 présente William R. Jellison en tant que directeur de Medtronic plc (MDT) et indique qu’il ne détient pas, de manière bénéficiaire, d’actions ordinaires ni de titres dérivés. Le dépôt a été soumis comme déclaration initiale et signé par un mandataire. Aucune transaction, participation ou intérêt de propriété indirecte n’est reporté.

Medtronic-Direktor meldet keine begünstigten Eigentumsverhältnisse. Das Formular 3 führt William R. Jellison als Direktor von Medtronic plc (MDT) auf und gibt an, dass er keine Beneficial Ownership an normalen Aktien oder derivativen Wertpapieren besitzt. Die Einreichung erfolgte als anfängliche Erklärung und wurde von einem Bevollmächtigten unterschrieben. Es werden keine Transaktionen, Beteiligungen oder indirekten Eigentumsinteressen gemeldet.

مدير Medtronic يقدم تقريراً يفيد بأنه لا يملك ملكية مستفيدة. يُظهر النموذج 3 ويليام ر. جيليسون كمدير في Medtronic plc (MDT) ويدل على أنه لا يمتلك بشكل مستفيد أي أسهم عادية أو أوراق مالية مشتقة. تم تقديم الملف كتصريح ابتدائي وتوقعه وكيل بذاته. لا تُذكر معاملات أو حيازات أو مصالح ملكية غير مباشرة في التقرير.

Medtronic 董事申报未拥有受益所有权。 表格3显示 William R. Jellison 为 Medtronic plc (MDT) 的董事,并说明他对任何普通股或衍生证券不享有受益所有权。此申报作为初始声明提交,由代理人签名。未报告任何交易、持股或间接所有权。

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Jellison William R

(Last) (First) (Middle)
C/O MEDTRONIC
710 MEDTRONIC PARKWAY

(Street)
MINNEAPOLIS MN 55432

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/19/2025
3. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 0(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. No securities are beneficially owned.
Remarks:
/s/ Patricia Walesiewicz, attorney-in-fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Medtronic

NYSE:MDT

MDT Rankings

MDT Latest News

MDT Latest SEC Filings

MDT Stock Data

117.65B
1.28B
0.3%
87.24%
1.03%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
Ireland
GALWAY